Brief: Fractyl Health Announces Compelling 6-Month Randomized Remain-1 Midpoint Data Showing Durable Weight Maintenance With Revita® After Glp-1 Discontinuation
29/01/2026 12:22
Jan 29 (Reuters) - Fractyl Health Inc GUTS.O: FRACTYL HEALTH ANNOUNCES COMPELLING 6-MONTH RANDOMIZED REMAIN-1 MIDPOINT DATA SHOWING DURABLE WEIGHT MAINTENANCE WITH REVITA® AFTER GLP-1 DISCONTINUATION FRACTYL HEALTH INC - REVITA-TREATED PATIENTS SHOW 4.5% WEIGHT REGAIN VERSUS 7.5% SHAM FRACTYL HEALTH INC - REQUESTED FDA FEEDBACK ON REVITA DE NOVO PATHWAY FRACTYL HEALTH INC: EXPECTS FDA FEEDBACK REGARDING POTENTIAL FOR USE OF DE NOVO PATHWAY IN Q2 OF 2026 FRACTYL HEALTH INC - REVITA SHOWS 4.2% WEIGHT REGAIN VERSUS 13.3% SHAM Source text: ID:nGNXbxg2kw Further company coverage: GUTS.O ((Reuters.Briefs@thomsonreuters.com;))